期刊文献+

疫苗的质量管理与监管检查 被引量:7

Vaccine Quality Management and Regulatory Inspection
下载PDF
导出
摘要 疫苗直接用于健康人群,尤其是新生儿和青少年,与人民的健康联系紧密,属于高风险的特殊商品。疫苗的生产与质量控制过程十分复杂,疫苗生产企业必须运用质量风险管理的理念,进行全过程的质量管理才能保证其质量。疫苗生产周期长、很多关键产品质量指标不能从最终产品放行检验中获得,只有将检查重点置于疫苗生产与质量控制的高风险环节,才能降低检查工作本身存在的风险。 Vaccine is used in healthy people directly, especially the newborns and youth. It is in close contact with the public health. And it belongs to high-risk merchandise. The production and quality control process for vaccine is very complex. In order to ensure the vaccine quality, the manufacturers must adopt quality risk management approach and use it to the whole process of quality management. As the vaccine production cycle is long, and many key quality indicators could not be found through final product release testing. The regulatory inspection works become hard. To reduce the risk, it is important to go through the high-risk areas of the vaccine production and quality control during the inspection.
作者 孙京林
出处 《中国药物评价》 2014年第1期48-50,60,共4页 Chinese Journal of Drug Evaluation
关键词 疫苗 质量管理 监管检查 质量风险管理 Vaccines Quality Management Regulatory Inspection Quality Risk Management
  • 相关文献

参考文献3

  • 1(美)普洛特金(Plotkin,S.)著;梁晓峰等译疫苗学[M].第5版.北京:人民卫生出版社,2011.
  • 2药品生产质量管理规范(2010年修订)(卫生部令第79号)[EB/OL].(2011-01-17)[2012-08-28].http://www.sda.gov.cn/WS01/CL0053/58500.html.
  • 3Department of Health and Human Services, U. S. Food and Drug Adminis- tration. Pharmaceutical cGMPs for the 21st Century-A Risk-Based Approach: FinalReport-Fall 2004 [EB/OL. [2004)9]. http://www, fda. gov/ drugs/developmentapprovalprocess/manufacturing/qnestionsandanswersoncur- pfordrugs/ucm137175, htm.

同被引文献40

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部